India’s Bioeconomy Growth Story

 

1. India’s bioeconomy expanded from USD 10 billion in 2014 to USD 165.7 billion in 2024, and contributed about 4.25 percent to a national GDP of USD 3.89 trillion.

2. India aims to raise its bioeconomy to USD 300 billion by 2030, reflecting the sector’s growing importance in sustainable growth, innovation, biotechnology, healthcare, and industrial transformation.

3. In 2024, BioIndustrial was the largest bioeconomy subsector at USD 78.2 billion, accounting for 47 percent, followed by BioPharma and BioMedical at USD 58.4 billion.

4. BioAgri contributed USD 13.5 billion or 8.1 percent of the bioeconomy in 2024, while BioResearch and BioIT held a 9.4 percent share worth USD 15.6 billion.

5. Maharashtra led India’s bioeconomy in 2024 with USD 35.45 billion, representing 21.4 percent, followed by Karnataka at USD 32.4 billion and Telangana at USD 19.9 billion.

6. The Southern region contributed 45.4 percent of India’s bioeconomy in 2024 with USD 75.2 billion, while the Western region accounted for 30.3 percent or USD 50.2 billion.

7. The BioE3 Policy was approved by the Union Cabinet on 24 August 2024 as India’s first biotechnology policy focused on biomanufacturing, biofoundries, green growth, and sustainability.

8. India launched 21 advanced BioEnabler facilities to provide shared infrastructure for startups, SMEs, industries, and academic institutions in areas such as smart proteins, marine biotechnology, and gene therapies.

9. The BioE3 Challenge for Youth begins from October 2025, with ten best entries each month receiving ₹1 lakh, while 100 participants can receive support up to ₹25 lakh.

10. India achieved 20 percent ethanol blending in petrol in 2025, five years ahead of target, rising sharply from 1.5 percent blending recorded in 2014.

11. Between ESY 2014–15 and June 2025, farmers received ₹1,21,000 crore for ethanol feedstock, while 20 percent blending is expected to generate ₹40,000 crore payments in one year.

12. Till July 2025, ethanol blending substituted 245 lakh metric tonnes of crude oil and saved ₹1,44,087 crore in foreign exchange, strengthening energy security and reducing import dependence.

13. Serum Institute of India’s share of the global vaccine market, excluding COVID-19 vaccines, rose from 19 percent in 2021 to 24 percent in 2024.

14. India’s biotech startup ecosystem grew from 5,365 startups in 2021 to 13,000 in 2025, a rise of 142 percent, with over 800 products developed.

15. India’s bioeconomy could grow from USD 165.7 billion in 2024 to between USD 1.4 trillion and USD 2.7 trillion by 2050, contributing 6.5 to 12 percent of GDP.

Must Know Terms :

 

1.BioE3

BioE3 is India’s first biotechnology policy, approved on 24 August 2024. The name stands for Biotechnology for Economy, Environment and Employment. It focuses on high performance biomanufacturing, biofoundries, and regenerative industrial practices. The policy supports green growth by encouraging sustainable production systems, shared infrastructure, and innovation across sectors such as agriculture, health, functional foods, and carbon capture in India today.

2.BioIndustrial

BioIndustrial was the largest component of India’s bioeconomy in 2024, valued at USD 78.2 billion and contributing 47 percent. It includes biofuels, chemicals, bioplastics, enzymes, and industrial applications based on biosynthetic processes and recombinant DNA technology. Its expansion reflects India’s growing move toward green manufacturing, circular economy practices, reduced fossil dependence, and wider adoption of sustainable bio-based industrial solutions nationwide.

3.BioPharma

BioPharma and BioMedical formed 35.2 percent of India’s bioeconomy in 2024, with a value of USD 58.4 billion. This segment covers pharmaceuticals, biologics, diagnostics, medical devices, organoids, and advanced therapeutic research. It supports affordable healthcare innovation and work in cancer immunotherapy, gene editing, precision medicine, and MedTech. India’s global reputation in affordable biopharmaceutical production strengthens this segment globally today.

4. BioAgri

BioAgri contributed USD 13.5 billion to India’s bioeconomy in 2024 and accounted for 8.1 percent of the total value. This subsector centres on agricultural biotechnology, including genetically modified crops, precision farming, and bio-based agricultural products. Bt Cotton remains one of its best known examples. The segment supports higher productivity, improved sustainability, farm practices, and wider use of biotechnology in agriculture.

5. Ethanol

Ethanol blending reached 20 percent in petrol in 2025, achieving the target five years ahead of schedule. It rose sharply from 1.5 percent in 2014. Between Ethanol Supply Year 2014–15 and June 2025, farmers received ₹1,21,000 crore for ethanol feedstock. Till July 2025, blending substituted 245 lakh metric tonnes of crude oil and saved ₹1,44,087 crore in foreign exchange cumulatively.

6. BioEnablers

BioEnablers are advanced shared facilities created to support India’s biotechnology ecosystem under the biomanufacturing push. A total of 21 such facilities have been launched across the country. They provide infrastructure access for startups, SMEs, industries, and academic institutions. Their focus areas include microbial biomanufacturing, smart proteins, agriculture, functional foods, carbon capture, marine biotechnology, and next-generation cell and gene therapies nationwide.

Key takeaways

 

a) India’s bioeconomy grew from USD 10 bn (2014) to USD 165.7 bn (2024), targeting USD 300 bnby 2030.

b) Four key subsectors: BioIndustrial (47%), BioPharma (35%), BioAgri (8%), and BioResearch (9%).

c) Achieved 20% ethanol blending in 2025, five years ahead of target, boosting farmer income and forex savings.

d) India is a global vaccine hub, with Serum Institute’s share rising to 24% in 2024.

MCQ :

1. India’s bioeconomy increased from USD 10 billion in 2014 to which of the following levels in 2024?

A) USD 145.7 billion
B) USD 165.7 billion
C) USD 175.7 billion
D) USD 185.7 billion

2. India’s bioeconomy contributed about what share to a national GDP of USD 3.89 trillion in 2024?

A) 4.25 percent
B) 5.25 percent
C) 3.25 percent
D) 6.25 percent

3. India has set a target of raising its bioeconomy to which of the following levels by 2030?

A) USD 200 billion
B) USD 250 billion
C) USD 300 billion
D) USD 350 billion

4. Which one of the following was the largest subsector of India’s bioeconomy in 2024?

A) BioAgri
B) BioResearch and BioIT
C) BioPharma and BioMedical
D) BioIndustrial

5. BioIndustrial accounted for what share of India’s bioeconomy in 2024?

A) 35 percent
B) 47 percent
C) 8.1 percent
D) 9.4 percent

6. BioAgri contributed which of the following amounts to India’s bioeconomy in 2024?

A) USD 15.6 billion
B) USD 58.4 billion
C) USD 13.5 billion
D) USD 78.2 billion

7. Which state led India’s bioeconomy in 2024?

A) Karnataka
B) Maharashtra
C) Telangana
D) Gujarat

8. The Southern region contributed what share of India’s bioeconomy in 2024?

A) 30.3 percent
B) 18.5 percent
C) 45.4 percent
D) 21.4 percent

9. The BioE3 Policy was approved by the Union Cabinet on:

A) 24 August 2024
B) 25 August 2025
C) 5 September 2025
D) 24 August 2025

10. How many advanced BioEnabler facilities were launched across India?

A) 11
B) 15
C) 21
D) 25

11. Under the BioE3 Challenge for Youth, the ten best entries each month receive:

A) ₹50,000
B) ₹1 lakh
C) ₹5 lakh
D) ₹25 lakh

12. India achieved 20 percent ethanol blending in petrol in:

A) 2023
B) 2024
C) 2025
D) 2030

13. Between Ethanol Supply Year 2014–15 and June 2025, farmers received how much for ethanol feedstock?

A) ₹1,44,087 crore
B) ₹40,000 crore
C) ₹76,000 crore
D) ₹1,21,000 crore

14. Till July 2025, ethanol blending substituted how many lakh metric tonnes of crude oil?

A) 145 lakh metric tonnes
B) 245 lakh metric tonnes
C) 345 lakh metric tonnes
D) 445 lakh metric tonnes

15. Serum Institute of India’s share of the global vaccine market, excluding COVID-19 vaccines, rose to what level in 2024?

A) 19 percent
B) 20 percent
C) 22 percent
D) 24 percent